Trophoblast membrane infusion for unexplained recurrent miscarriage
- 1 April 1988
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 95 (4), 342-347
- https://doi.org/10.1111/j.1471-0528.1988.tb06603.x
Abstract
Summary. A novel protocol is described which has been developed for immunotherapy in unexplained recurrent miscarriage. This is based on a single intravenous infusion with isolated placental trophoblast plasma membrane vesicle preparations. Clinical experience gained with this approach is described. A total of 16/21 (76%) patients who subsequently had pregnancies have now achieved a live birth or are currently pregnant at greater than 28 weeks gestation.This publication has 20 references indexed in Scilit:
- Immunogenetic Studies in Habitual AbortionAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1987
- Immunologic Testing and Immunotherapy in Recurrent Spontaneous AbortionObstetrics & Gynecology, 1986
- Antibody reactivity against trophoblast and trophoblast productsJournal of Reproductive Immunology, 1985
- Hereditary Hemorrhagic Telangiectasia and Factor VIII InhibitorSouthern Medical Journal, 1985
- CONTROLLED TRIAL OF TREATMENT OF RECURRENT SPONTANEOUS ABORTION BY IMMUNISATION WITH PATERNAL CELLSThe Lancet, 1985
- Tissue factor (coagulation factor III) is present in placental microvilli and cofractionates with microvilli membrane proteinsPlacenta, 1985
- IMMUNOBIOLOGY OF THE HUMAN TROPHOBLASTPublished by Elsevier ,1984
- TROPHOBLAST SURVIVALTransplantation, 1981
- Preparation of human placental villous surface membraneNature, 1974
- EMBOLISM TO THE LUNGS BY TROPHOBLASTBJOG: An International Journal of Obstetrics and Gynaecology, 1961